After Covishield Serum Institute of India will launch Indian version of Novavax by June 2021

[Suriya]

https://twitter.com/x/status/1355421280539791360

Another Vaccine in India? Poonawalla Says Covovax Shown ‘Excellent Results’, Hopes to Launch it by June

Representative image.
Poonawalla said that SII's partnership with Novavax, a vaccine undergoing trials for effectiveness against the novel coronavirus, has published 'excellent efficacy results'.

• NEWS18.COM
• LAST UPDATED:JANUARY 30, 2021, 15:50 IST
• FOLLOW US ON:

Aday after Serum Institute of India (SII) sought the Drugs Controller General of India’s approval to conduct a small domestic trial of the Novavax coronavirus vaccine, its Chief Executive Officer Adar Poonawalla on Saturday the company is hopeful of launching the vaccine by June this year.
The vaccine will be launched under the local brand Covovax.


Poonawalla said that SII's partnership with Novavax, a vaccine undergoing trials for effectiveness against the novel coronavirus, has published 'excellent efficacy results'.
“Our partnership for a COVID-19 vaccine with @Novavax has also published excellent efficacy results. We have also applied to start trials in India. Hope to launch #COVOVAX by June 2021!” he said in a tweet.

Pune-based SII, the world's largest vaccine manufacturer, and the Indian Council of Medical Research have a tie-up with the company and bridging studies will be done once the regulators give the approval.
SII's application with the DCGI is being examined. A bridging trial is a supplementary trial performed in a new region or country to get more clinical data on efficacy, safety and dose regimen.

Earlier, Dr Umesh Shaligram, executive director of SII, told News18 that the company is keen on starting the bridging trials in the country and that SII would be in a position to start the trials by February once the approvals come through. “Data of protection against the new variants is promising. The good thing is that the new strain in South Africa emerged as the trials of the vaccine were going on in the country,” he said.

In September 2020, Novavax had announced its deal with Serum Institute to produce 2 billion doses of the Covid-19 vaccines. In India, the vaccine will be called Covovax, developed by Novavax and upscaled by the SII.

Another Vaccine in India? Poonawalla Says Covovax Shown ‘Excellent Results’, Hopes to Launch it by June - News18

Poonawalla said that SII's partnership with Novavax, a vaccine undergoing trials for effectiveness against the novel coronavirus, has published 'excellent efficacy results'.

www.news18.com

 

[Protest_again]

PDF will loose its wits.

 

[Suriya]

PDF will loose its wits.

They are going to export too. So Pakistan can avail them too. Anyway Novavax has shown impressive result.

@Vapnope you see whether Covishiel/AstraZeneca or Covovax/Novavax, these are commercial deals signed by Sirum Institute for the manufacture of the same even before their trial began. And it is solely Sirum Institute which decides the who it is going to sell and at what price and not original developers as long as it doses manufactured remain within the number the contract signed for.

 

[Kyusuibu Honbu]

Success of Novavax is good news for India

Considering India has preordered 1 billion Novavax vaccines for its citizens

Using its massive manufacturing clout, the country purchased 500 million doses of the Oxford University-AstraZeneca vaccine candidate, one billion doses from American firm Novavax and 100 million doses of the Sputnik V candidate from Russia's Gamaleya Research Institute, said the US-based Duke University Global Health Innovation Centre.

India buys 1.6b vaccine doses, said to be most in the world

 

[Suriya]

Success of Novoax is good news for India

Considering India has preordered 1 billion Novovax vaccines for its citizens



India buys 1.6b vaccine doses, said to be most in the world

In September 2020, Novavax had announced its deal with Serum Institute to produce 2 billion doses of the Covid-19 vaccines. In India, the vaccine will be called Covovax, developed by Novavax and upscaled by the SII.

 

[Kyusuibu Honbu]

In September 2020, Novavax had announced its deal with Serum Institute to produce 2 billion doses of the Covid-19 vaccines. In India, the vaccine will be called Covovax, developed by Novavax and upscaled by the SII.

So 1 billion for export, 1 billion for domestic vaccinations

Consistent with our 50-50 vaccine manufacturing for domestic and export demand

 

[Vapnope]

They are going to export too. So Pakistan can avail them too. Anyway Novavax has shown impressive result.

@Vapnope you see whether Covishiel/AstraZeneca or Covovax/Novavax, these are commercial deals signed by Sirum Institute for the manufacture of the same even before their trial began. And it is solely Sirum Institute which decides the who it is going to sell and at what price and not original developers as long as it doses manufactured remain within the number the contract signed for.

Correct me if wrong, isn't it that vaccine manufacturing order is placed to this Indian pharma and the patent holder is buying these medicines from this pharma?

 

[xeuss]

Correct me if wrong, isn't it that vaccine manufacturing order is placed to this Indian pharma and the patent holder is buying these medicines from this pharma?

I believe some part produced on order for the patent holder, while the other is produced under license. Therefore, Covavax, is produced under license (paying royalty to Novavax) and will only be sold in India (and maybe some other geographic regions, depending on agreement signed).

 

[Suriya]

Correct me if wrong, isn't it that vaccine manufacturing order is placed to this Indian pharma and the patent holder is buying these medicines from this pharma?

No, only royalty is paid under licensed agreement and it has been sold under a different name in different geographic regions agreed between them. Covishield is generic version but not product of AstraZeneca
That means AstraZeneca isn't using Serum institute as manufacturing facility.
and Covishield would separate permission other than AstraZeneca to sell it's vaccine in any country.

 

[Turingsage]

Pakistan is going to receive 17 million doses produced by the Serum Institute of India as part of the SUBSIDISED AND FREE International program

Pakistan has received FREE 0.5 million Sinovac from China and will receive 17 million doses of AZ vaccine from India. Supplied under the COVAX program of the WHO. Pakistan expects Baksheesh and free vaccines for its population and does not want to spend money saving the lives of Pakistani Awam.

""""
An official of the Ministry of National Health Services, meanwhile, said the efficacy rate of Chinese Sinopharm’s vaccine was around 80 per cent but Oxford-AstraZeneca’s efficacy was around 90pc.

“Though AstraZeneca is being prepared in India, it will come through Covax, an international alliance which has announced free vaccine for 20pc of Pakistan’s population. Drap has already registered both Sinopharm and AstraZeneca,” the special assistant said.""""

Dawn

 

[Vapnope]

No, only royalty is paid under licensed agreement and it has been sold under a different name in different geographic regions agreed between them. Covishield is generic version but not product of AstraZeneca
That means AstraZeneca isn't using Serum institute as manufacturing facility.
and Covishield would separate permission other than AstraZeneca to sell it's vaccine in any country.

Thanks.

 

[Flash_Ninja]

Pakistan is going to receive 17 million doses produced by the Serum Institute of India as part of the SUBSIDISED AND FREE International program

Pakistan has received FREE 0.5 million Sinovac from China and will receive 17 million doses of AZ vaccine from India. Supplied under the COVAX program of the WHO. Pakistan expects Baksheesh and free vaccines for its population and does not want to spend money saving the lives of Pakistani Awam.

""""
An official of the Ministry of National Health Services, meanwhile, said the efficacy rate of Chinese Sinopharm’s vaccine was around 80 per cent but Oxford-AstraZeneca’s efficacy was around 90pc.

“Though AstraZeneca is being prepared in India, it will come through Covax, an international alliance which has announced free vaccine for 20pc of Pakistan’s population. Drap has already registered both Sinopharm and AstraZeneca,” the special assistant said.""""

Dawn

Thread is about a foreign vaccine being produced in India, yet this baboon is so obsessed that they decide to drag Pakistan into it

Oh and if you can ever spare a brain cell and look into this program you will realise that India is part of it too, which makes your post all the more pathetic.